ID21472A - Senyawa terbaru yang berguna sebagai agen pelindung saraf - Google Patents

Senyawa terbaru yang berguna sebagai agen pelindung saraf

Info

Publication number: ID21472A
Authority: ID; Indonesia
Prior art keywords: protective agent; nervous; latest; compounds; latest compounds
Prior art date: 1996-10-07

Application number

IDW990301A

Other languages

English (en)

Inventor

Lawrence Joseph Heinz

Jill Ann Panetta

Michael Leroyphillips

John Kevin Shadle

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-07

Filing date

1997-10-06

Publication date

1999-06-17

1997-10-06 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1999-06-17 Publication of ID21472A publication Critical patent/ID21472A/id

Links

150000001875 compounds Chemical class 0.000 title 1
239000003223 protective agent Substances 0.000 title 1
150000000183 1,3-benzoxazoles Chemical class 0.000 abstract 1
RQCBPOPQTLHDFC-UHFFFAOYSA-N 2-phenyl-1,3-oxazole Chemical class C1=COC(C=2C=CC=CC=2)=N1 RQCBPOPQTLHDFC-UHFFFAOYSA-N 0.000 abstract 1
239000004090 neuroprotective agent Substances 0.000 abstract 1
150000004866 oxadiazoles Chemical class 0.000 abstract 1
150000002918 oxazolines Chemical class 0.000 abstract 1
150000003557 thiazoles Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D263/57—Aryl or substituted aryl radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/26—Radicals substituted by sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Adhesives Or Adhesive Processes (AREA)
Liquid Crystal Substances (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Saccharide Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IDW990301A 1996-10-07 1997-10-06 Senyawa terbaru yang berguna sebagai agen pelindung saraf ID21472A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US2756096P	1996-10-07	1996-10-07

Publications (1)

Publication Number	Publication Date
ID21472A true ID21472A (id)	1999-06-17

Family

ID=21838447

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW990301A ID21472A (id)	1996-10-07	1997-10-06	Senyawa terbaru yang berguna sebagai agen pelindung saraf

Country Status (19)

Country	Link
US (4)	US6156748A (id)
EP (1)	EP0971709B1 (id)
CN (1)	CN1239889A (id)
AT (1)	ATE240728T1 (id)
AU (1)	AU721355B2 (id)
CA (1)	CA2270661A1 (id)
CZ (1)	CZ166399A3 (id)
DE (1)	DE69722258T2 (id)
DK (1)	DK0971709T3 (id)
EA (1)	EA001713B1 (id)
ES (1)	ES2199353T3 (id)
HU (1)	HUP9904682A3 (id)
ID (1)	ID21472A (id)
IL (1)	IL129748A (id)
NO (1)	NO313193B1 (id)
NZ (1)	NZ335610A (id)
PT (1)	PT971709E (id)
TR (1)	TR199901559T2 (id)
WO (1)	WO1998015274A1 (id)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0908180A3 (en) *	1997-08-28	1999-04-21	Eli Lilly And Company	Use of phenyl oxazole or phenyl thiazole derivatives for treating pain
US5952360A (en) *	1997-08-28	1999-09-14	Eli Lilly And Company	Method for treating neuropathic pain
US5942530A (en) *	1997-08-28	1999-08-24	Eli Lilly And Company	Method for treating pain
AU9575698A (en) *	1997-10-06	1999-04-27	Eli Lilly And Company	Novel compounds useful as neuro-protective agents
IT1300055B1 (it) *	1998-04-17	2000-04-05	Boehringer Ingelheim Italia	Eterocicli con anello a 5 termini difenil-sostituiti loro procedimento di preparazione e loro impiego come farmici
US7115750B1 (en)	1999-09-20	2006-10-03	Takeda Pharmaceutical Company Limited	Melanin concentrating hormone antagonist
TWI283577B (en) *	1999-10-11	2007-07-11	Sod Conseils Rech Applic	Pharmaceutical composition of imidazole derivatives acting as modulators of sodium channels and the use thereof
RU2380362C2 (ru) *	1999-10-11	2010-01-27	Сосьете Де Консей Де Решерш З	Производные пятичленных гетероциклов, способ их получения и их применение в качестве лекарственных средств
FR2812546B1 (fr) *	2000-08-01	2008-11-21	Sod Conseils Rech Applic	Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments
PT1285651E (pt)	2000-04-28	2010-10-21	Takeda Pharmaceutical	Antagonistas da hormona concentradora da melanina
JP2004531479A (ja) *	2001-02-08	2004-10-14	カロバイオアクチェブラーグ	甲状腺受容体リガンドとしてのフェノキシ置換されたベンゾ縮合ヘテロアリール誘導体
US7091357B2 (en) *	2001-12-26	2006-08-15	University Of Kentucky Research Foundation	Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologies
WO2004005267A2 (en)	2002-07-03	2004-01-15	Janssen Pharmaceutica, N.V.	Heteroaryl compounds useful in treating inflammatory disorders
SI2656854T1 (sl) *	2003-02-04	2015-09-30	Cornell Research Foundation, Inc.	Uporabe aromatsko-kationskega peptida
TW200505913A (en)	2003-03-28	2005-02-16	Hoffmann La Roche	Novel oxazole derivatives, their manufacture and use as pharmaceutical agents
US7353897B2 (en) *	2003-07-23	2008-04-08	Fernandez Dennis S	Telematic method and apparatus with integrated power source
CA3024434A1 (en)	2004-01-23	2005-08-11	Cornell Research Foundation, Inc.	Methods for reducing oxidative damage
TWI330639B (en)	2005-11-15	2010-09-21	Otsuka Pharma Co Ltd	Oxazole compound and pharmaceutical composition
EA025178B1 (ru)	2010-09-06	2016-11-30	Айгис Аг	Проточный аккумулятор и способ преобразования электрической энергии с его использованием
US10881162B2 (en)	2015-05-07	2021-01-05	Exero Labs LLC	Device for minimizing impact of collisions for a helmet
CN112826794B (zh)	2019-11-06	2022-02-11	上海交通大学医学院	一种靶向修复神经血管病变的纳米复合物及其制备与应用
WO2024040267A2 (en) *	2022-08-19	2024-02-22	Mitokinin, Inc.	Direct synthesis of n-(3-substituted-chroman-4-yl)-7h- pyrrolo[2,3-d]pyrimidin-4-amines and derivatives thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4636516A (en) *	1981-02-19	1987-01-13	Yamanouchi Pharmaceutical Co., Ltd.	3,5-di-tert-butyl-4-hydroxyphenyl-substituted heterocyclic compounds
DE3425118A1 (de) *	1984-07-07	1986-01-16	Boehringer Mannheim Gmbh, 6800 Mannheim	Neue redox-indikatoren
GB8531608D0 (en) *	1985-12-23	1986-02-05	Beecham Group Plc	Treatment
DE3621775A1 (de) *	1986-03-13	1988-01-07	Thomae Gmbh Dr K	Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3903993A1 (de) *	1989-02-10	1990-08-16	Basf Ag	Diarylsubstituierte heterocyclische verbindungen, ihre herstellung und arzneimittel daraus
CA2009470A1 (en) *	1989-02-08	1990-08-08	Yu Momose	Oxazole compounds and their use
CA2073981C (en) *	1990-11-30	2002-01-08	Shiro Kondo	2-arylthiazole derivatives and pharmaceutical composition thereof
US5633271A (en) *	1992-05-26	1997-05-27	E. I. Du Pont De Nemours And Company	Arthropodicidal oxazolines and thiazolines
DE4304197A1 (de) *	1993-02-12	1994-08-18	Bayer Ag	Substituierte Oxazole
US5428048A (en) *	1993-11-08	1995-06-27	American Home Products Corporation	Aryl-N-hydroxyureas as inhibitors of 5-lipoxygenase and anto-arteriosclerotic agents
US6251928B1 (en) *	1994-03-16	2001-06-26	Eli Lilly And Company	Treatment of alzheimer's disease employing inhibitors of cathepsin D
EP0908180A3 (en) *	1997-08-28	1999-04-21	Eli Lilly And Company	Use of phenyl oxazole or phenyl thiazole derivatives for treating pain
US5942530A (en) *	1997-08-28	1999-08-24	Eli Lilly And Company	Method for treating pain
US5952360A (en) *	1997-08-28	1999-09-14	Eli Lilly And Company	Method for treating neuropathic pain
AU9575698A (en) *	1997-10-06	1999-04-27	Eli Lilly And Company	Novel compounds useful as neuro-protective agents

1997
- 1997-10-06 CA CA002270661A patent/CA2270661A1/en not_active Abandoned
- 1997-10-06 ID IDW990301A patent/ID21472A/id unknown
- 1997-10-06 AU AU47459/97A patent/AU721355B2/en not_active Ceased
- 1997-10-06 DK DK97909975T patent/DK0971709T3/da active
- 1997-10-06 CZ CZ991663A patent/CZ166399A3/cs unknown
- 1997-10-06 EA EA199900362A patent/EA001713B1/ru not_active IP Right Cessation
- 1997-10-06 IL IL12974897A patent/IL129748A/xx not_active IP Right Cessation
- 1997-10-06 US US08/944,468 patent/US6156748A/en not_active Expired - Fee Related
- 1997-10-06 NZ NZ335610A patent/NZ335610A/xx unknown
- 1997-10-06 EP EP97909975A patent/EP0971709B1/en not_active Expired - Lifetime
- 1997-10-06 HU HU9904682A patent/HUP9904682A3/hu unknown
- 1997-10-06 DE DE69722258T patent/DE69722258T2/de not_active Expired - Fee Related
- 1997-10-06 ES ES97909975T patent/ES2199353T3/es not_active Expired - Lifetime
- 1997-10-06 CN CN97180378A patent/CN1239889A/zh active Pending
- 1997-10-06 TR TR1999/01559T patent/TR199901559T2/xx unknown
- 1997-10-06 WO PCT/US1997/017963 patent/WO1998015274A1/en not_active Ceased
- 1997-10-06 PT PT97909975T patent/PT971709E/pt unknown
- 1997-10-06 AT AT97909975T patent/ATE240728T1/de not_active IP Right Cessation
1999
- 1999-05-07 NO NO19992226A patent/NO313193B1/no not_active IP Right Cessation
- 1999-08-04 US US09/368,236 patent/US6166216A/en not_active Expired - Fee Related
2000
- 2000-11-17 US US09/715,987 patent/US6380213B1/en not_active Expired - Fee Related
2001
- 2001-11-28 US US09/996,005 patent/US6423709B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
HUP9904682A2 (hu)	2000-05-28
US6423709B1 (en)	2002-07-23
ES2199353T3 (es)	2004-02-16
NO992226D0 (no)	1999-05-07
AU4745997A (en)	1998-05-05
US6380213B1 (en)	2002-04-30
CN1239889A (zh)	1999-12-29
EA199900362A1 (ru)	2000-02-28
US20020065274A1 (en)	2002-05-30
US6156748A (en)	2000-12-05
NZ335610A (en)	2000-10-27
CZ166399A3 (cs)	1999-11-17
ATE240728T1 (de)	2003-06-15
EP0971709B1 (en)	2003-05-21
IL129748A0 (en)	2000-02-29
TR199901559T2 (xx)	1999-09-21
NO313193B1 (no)	2002-08-26
NO992226L (no)	1999-05-27
HUP9904682A3 (en)	2001-09-28
EP0971709A4 (en)	2001-04-11
PT971709E (pt)	2003-09-30
DE69722258D1 (de)	2003-06-26
IL129748A (en)	2003-11-23
US6166216A (en)	2000-12-26
DK0971709T3 (da)	2003-09-22
CA2270661A1 (en)	1998-04-16
EP0971709A1 (en)	2000-01-19
WO1998015274A1 (en)	1998-04-16
AU721355B2 (en)	2000-06-29
EA001713B1 (ru)	2001-08-27
DE69722258T2 (de)	2004-03-18

Publication	Publication Date	Title
IL129748A0 (en)	2000-02-29	Novel compounds useful as neuro-protective agents
EP0908186A3 (en)	1999-04-21	Method for treating pain
NZ332762A (en)	2000-09-29	Isobutylgaba and its derivatives for the treatment of pain
HUP9801201A2 (hu)	2000-05-28	Taxoidok, előállításuk és ezeket tartalmazó gyógyszerkészítmények
GEP20094675B (en)	2009-05-10	Heteroaryl- tetra-hydropiperidyl compounds useful for treating or preventing pain
IL149582A0 (en)	2002-11-10	Substituted oxazoles and thiazoles derivative as hppar alpha activators
NO20043950L (no)	2004-10-13	3-cyklyl -5-(nitrogenholdig 5-leddet ring) metyl-oksazolidinon-derivater og deres anvendelse som antibakterielle midler
NO995846L (no)	2000-01-28	Oksazolidinon-antibakterielle midler med en tiokarbonylfunksjonalitet
BR9509673A (pt)	1997-09-30	Compostos e uso dos mesmos
CO4600675A1 (es)	1998-05-08	Derivados de oxalilamino-benzofurano y benzotienilo
IL142047A0 (en)	2002-03-10	Mglur5 antagonists for the treatment of pain and anxiety
BR0107667A (pt)	2002-10-08	Composto de linezolida em forma de cristal que e farmaceuticamente útil como agente antibacteriano e método de preparação do mesmo
DK1305037T3 (da)	2007-09-17	Smertestillende medikament
EP0908454A3 (en)	2001-07-25	Oxazoles, thiazoles, oxazolines, oxadiazoles and benzoxazoles useful as neuro-protective agents
NO20062629L (no)	2006-09-06	Oksazolderivater av tetrackliner
TW200505926A (en)	2005-02-16	1,4-diazabicyclo [3.2.2] nonanecarboxamide derivatives, preparation thereof and therapeutic use thereof
EP0908180A3 (en)	1999-04-21	Use of phenyl oxazole or phenyl thiazole derivatives for treating pain
SI1032386T1 (en)	2003-06-30	Use of oxazolidinone derivatives for treating arthritis
NO954892L (no)	1995-12-01	Heterosyklisk kjemi
PT1222857E (pt)	2004-05-31	Microbicidas
ES2060606T3 (es)	1994-12-01	Utilizacion de derivados de oxazolidinonas 5-(fenil-sustituido) para el tratamiento de depresiones.
DE69930952D1 (de)	2006-05-24	Gesteuerte freisetzung von antidepressiva
ATE329913T1 (de)	2006-07-15	Oxazole als mglur1 verstärker
PL336237A1 (en)	2000-06-19	Sulphonyloxadiazolones
NZ513724A (en)	2004-01-30	Anticonvulsant derivatives useful in treating essential tremor